Who was studied, and how
One number in the abstract
Where each one falls
Where it lands on the map
What it changes
Among 4 other studies
473people with kidney disease, in this paper
The trial randomly assignedassigned by chance
liraglutide
control
Probably lowered albumin-to-creatinine ratio−11.8
randomisedthe abstract, start to end
… significantly reduced ACR (WMD: - 11.76 mg/g, 95% CI, - 21.71 to - …
← favours treatmentfavours comparator →
could be chanceAlbumin-to-creatinine ratio (ACR)liraglutide vs control
−11.8−21.7 to −1.81
GLP-1 receptor agonistsKidney outcomes
GLP-1 receptor agonists × kidney outcomeshelps?mixed
unlikelylikely
0.50not counted
← favours treatmentfavours comparator →
1 / 6